academic article

• Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide..  Leukemia & lymphoma.  :1-9. 2016
• Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma..  American journal of hematology.  89:62-67. 2014
• Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. 2012
• Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker..  British journal of cancer.  101:1044-1050. 2009
• Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response..  Cancer.  113:2646-2654. 2008
• Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies..  Digestive diseases and sciences.  53:2090-2100. 2008
• Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. 2007
• Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression..  Clinical cancer research : an official journal of the American Association for Cancer Research.  12:20-28. 2006
• Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells..  Clinical cancer research : an official journal of the American Association for Cancer Research.  12:11-19. 2006